home / stock / nvs / nvs news


NVS News and Press, Novartis AG From 02/11/26

Stock Information

Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com

Menu

NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...

NVS - Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff

2026-02-11 10:00:00 ET It takes all the running you can do to keep in the same place. If you want to get somewhere else, you must run at least twice as fast! —Through the Looking-Glass (Lewis Carroll) Looking Back About 1.5 years ago, I opened a Long p...

NVS - AVDE: Diversified And Effective Active ETF At A Low Cost

2026-02-10 12:39:35 ET Strategy Avantis International Equity ETF ( AVDE ) is an actively managed fund launched on 09/24/2019. AVDE has a broad portfolio of 3249 stocks, a trailing 12-month yield of 2.42%, and an expense ratio of 0.23%. Distributions are paid quarterly.... ...

NVS - Oakmark International Strategy adds Unilever, Sanofi in Q4, exits Novartis

2026-02-10 09:33:04 ET More on related tickers Novartis: Value Price, Growth Pipeline Magnum Ice Cream rallies to a post-Unilever separation high Sanofi signs share buyback for up to €1B Read the full article on Seeking Alpha For further detail...

NVS - Oakmark International Strategy Q4 2025 New Investments And Divestments

2026-02-08 12:20:00 ET ... Read the full article on Seeking Alpha For further details see: Oakmark International Strategy Q4 2025 New Investments And Divestments

NVS - Novartis breaks ground on new R&D center in San Diego

2026-02-06 15:31:05 ET More on Novartis Novartis: Value Price, Growth Pipeline Novartis AG 2025 Q4 - Results - Earnings Call Presentation Novartis AG (NVS) Q4 2025 Earnings Call Transcript Novartis reports mixed Q4 results; initiates FY26 soft outlook ...

NVS - Novartis (NVS) Q3 2024 Earnings Call Transcript

2026-02-05 12:09:37 ET Image source: The Motley Fool. Tuesday, October 29, 2024 at 9 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

NVS - Novartis: Value Price, Growth Pipeline

2026-02-05 05:51:28 ET While many people are focusing on Tech and AI companies, I think we may have an opportunity for Value Investing within the Pharmaceutical industry, and specifically with the stock Novartis ( NVS ). Itis a great example of an underappreciated stock in the Globa...

NVS - Novartis AG (NVS) Q4 2025 Earnings Call Transcript

2026-02-04 16:40:45 ET Novartis AG (NVS) Q4 2025 Earnings Call February 4, 2026 8:00 AM EST Company Participants Sloan Simpson - Global Head of Investor Relations Vasant Narasimhan - Chief Executive Officer Harry Kirsch - Chief Financial Officer Mukul Mehta ...

NVS - Hikma Pharmaceuticals gains amid takeover speculation

2026-02-04 11:47:46 ET More on Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC (HKMPY) Shareholder/Analyst Call Transcript Seeking Alpha’s Quant Rating on Hikma Pharmaceuticals PLC Historical earnings data for Hikma Pharmaceuticals PLC Dividend sco...

NVS - Expected US Company Earnings on Wednesday, February 4th, 2026

Central Garden & Pet Company (CENT) is expected to report $0.11 for Q1 2026 Eli Lilly and Company (LLY) is expected to report $6.99 for Q4 2025 The Ensign Group Inc. (ENSG) is expected to report $1.59 for Q4 2025 McKesson Corporation (MCK) is expected to report $9.31 for Q3 2026 ...

Previous 10 Next 10